SCLX - Scilex Holding Co
8.48
0.060 0.708%
Share volume: 22,584
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$8.42
0.06
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-13-2024 | 01-17-2025 | 05-14-2025 | 11-14-2025 | |
| Assets | ||||||
| Total Assets | 91.240 M | 104.544 M | 100.430 M | 78.976 M | 275.879 M | |
| Current Assets | 37.745 M | 50.418 M | 39.855 M | 28.704 M | 16.487 M | |
| Inventories | 3.486 M | 3.073 M | 2.404 M | 3.017 M | 1.082 M | |
| Other Current Assets | 2.725 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 2.725 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 29.716 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.818 M | 6.888 M | 77.000 K | 5.800 M | 878.000 K | |
| Total Non-current Assets | 53.495 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 718.000 K | 714.000 K | 711.000 K | 707.000 K | 703.000 K | |
| Other Assets | 3.838 M | 53.412 M | 59.864 M | 49.565 M | 258.689 M | |
| Intangible Assets | 35.458 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 13.481 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 91.240 M | 104.544 M | 100.430 M | 78.976 M | 275.879 M | |
| Total liabilities | 281.026 M | 319.236 M | 311.747 M | 290.460 M | 455.598 M | |
| Total current liabilities | 252.732 M | 255.451 M | 281.537 M | 275.744 M | 358.948 M | |
| Accounts Payable | 42.219 M | 41.787 M | 43.400 M | 57.257 M | 67.362 M | |
| Other liabilities | 9.903 M | 34.752 M | 15.878 M | 14.716 M | 96.650 M | |
| Current long term debt | 93.654 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 18.391 M | 29.033 M | 14.332 M | 0.000 | 0.000 | |
| Other liabilities | 9.903 M | 34.752 M | 15.878 M | 14.716 M | 96.650 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -189.786 M | -214.692 M | -211.317 M | -211.485 M | -176.937 M | |
| Common stock | 102.407 M | 426.183 M | 430.786 M | 448.245 M | 785.305 M | |
| Retained earnings | -514.622 M | -552.204 M | -556.592 M | -589.132 M | -888.674 M |